Rafferty Asset Management
RVMD icon

Rafferty Asset Management’s Revolution Medicines RVMD Stock Holding History

Rafferty Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Sell
19,145
-26,146
-58% -$3.82M 0.01% 463
2026
Q1 		$4.4M Sell
45,291
-29,407
-39% -$2.97M 0.02% 428
2025
Q4 		$5.95M Sell
74,698
-105,135
-58% -$6.89M 0.02% 382
2025
Q3 		$8.4M Buy
179,833
+26,855
+18% +$1.05M 0.03% 317
2025
Q2 		$5.63M Sell
152,978
-10,441
-6% -$401K 0.02% 375
2025
Q1 		$5.78M Sell
163,419
-9,367
-5% -$380K 0.02% 338
2024
Q4 		$7.56M Buy
172,786
+4,947
+3% +$250K 0.03% 331
2024
Q3 		$7.61M Sell
167,839
-17,798
-10% -$775K 0.03% 328
2024
Q2 		$7.2M Sell
185,637
-98,715
-35% -$3.69M 0.03% 336
2024
Q1 		$9.16M Sell
284,352
-80,743
-22% -$2.39M 0.03% 294
2023
Q4 		$10.5M Buy
365,095
+138,153
+61% +$3.32M 0.04% 264
2023
Q3 		$6.28M Sell
226,942
-98,001
-30% -$2.91M 0.04% 341
2023
Q2 		$8.69M Sell
324,943
-2,643
-0.8% -$64.8K 0.05% 238
2023
Q1 		$7.1M Buy
327,586
+90,268
+38% +$2.22M 0.05% 289
2022
Q4 		$5.65M Sell
237,318
-30,535
-11% -$649K 0.05% 351
2022
Q3 		$5.28M Buy
267,853
+164,852
+160% +$3.62M 0.06% 326
2022
Q2 		$2.01M Sell
103,001
-45,621
-31% -$888K 0.02% 462
2022
Q1 		$3.79M Sell
148,622
-8,911
-6% -$194K 0.02% 440
2021
Q4 		$3.96M Buy
157,533
+58,257
+59% +$1.64M 0.02% 466
2021
Q3 		$2.73M Buy
99,276
+23,162
+30% +$674K 0.02% 535
2021
Q2 		$2.42M Buy
76,114
+6,074
+9% +$212K 0.02% 621
2021
Q1 		$3.21M Buy
70,040
+53,992
+336% +$2.42M 0.02% 442
2020
Q4 		$635K Sell
16,048
-2,435
-13% -$96.3K 0.01% 629
2020
Q3 		$643K Buy
+18,483
New +$512K 0.01% 650

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Rafferty Asset Management's RVMD Position: Q2 2026 in Review

Rafferty Asset Management reduced its Revolution Medicines (RVMD) stake by 58% in Q2 2026, selling an estimated $3.82M and leaving 19,145 shares worth $3.59M. The position accounts for 0.01% of the portfolio, ranked #463.

Rafferty Asset Management first reported a position in RVMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.5M in Q4 2023. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Rafferty Asset Management held 19,145 shares of Revolution Medicines worth $3.59M as of Q2 2026.
  • Rafferty Asset Management sold 26,146 Revolution Medicines shares in Q2 2026, an estimated $3.82M.
  • Revolution Medicines made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #463 holding.
  • Rafferty Asset Management first reported a position in Revolution Medicines in Q3 2020 and has held it in 24 quarters since.
  • Rafferty Asset Management's Revolution Medicines position peaked at $10.5M in Q4 2023.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.